Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

379 ARTÍCULOS , VIENDO DEL 76 AL 90

Human CDC2-like kinase 1 (CLK1): a novel target for Alzheimer's disease

Jain P, Karthikeyan C, Moorthy NS, Waiker DK, Jain AK, Trivedi P.

Curr Drug Targets. 2014 May;15(5):539-50. doi: 10.2174/1389450115666140226112321.

Curcumin as a therapeutic agent in dementia: a mini systematic review of human studies

Brondino N, Re S, Boldrini A, Cuccomarino A, Lanati N, Barale F, Politi P.

ScientificWorldJournal. 2014 Jan 22;2014:174282. doi: 10.1155/2014/174282. eCollection 2014.

Retinoids as potential targets for Alzheimer's disease

Sodhi RK, Singh N.

Pharmacol Biochem Behav. 2014 May;120:117-23. doi: 10.1016/j.pbb.2014.02.016. Epub 2014 Feb 26.

The transdermal formulation of rivastigmine improves caregiver burden and treatment adherence of patients with Alzheimer's disease under daily practice conditions

Adler G, Mueller B, Articus K.

Int J Clin Pract. 2014 Apr;68(4):465-70. doi: 10.1111/ijcp.12374. Epub 2014 Mar 3.

Alzheimer's disease prevention & acetyl salicylic acid: a believable story

Pomponi M, Pomponi MF.

Indian J Med Res. 2014 Jan;139(1):1-3.

Amyloid-ß-directed immunotherapy for Alzheimer's disease

Lannfelt L, Relkin NR, Siemers ER.

J Intern Med. 2014 Mar;275(3):284-95. doi: 10.1111/joim.12168.

Antidementia drug use among community-dwelling individuals with Alzheimer's disease in Finland: a nationwide register-based study

Taipale H, Tanskanen A, Koponen M, Tolppanen AM, Tiihonen J, Hartikainen S.

Int Clin Psychopharmacol. 2014 Jul;29(4):216-23. doi: 10.1097/YIC.0000000000000032.

Hypertension and inflammation in Alzheimer's disease: close partners in disease development and progression!

Nelson L, Gard P, Tabet N.

J Alzheimers Dis. 2014;41(2):331-43. doi: 10.3233/JAD-140024.

The translocator protein as a drug target in Alzheimer's disease

Chua SW, Kassiou M, Ittner LM.

Expert Rev Neurother. 2014 Apr;14(4):439-48. doi: 10.1586/14737175.2014.896201.

Monoamine oxidase inhibitors: promising therapeutic agents for Alzheimer's disease (Review)

Cai Z.

Mol Med Rep. 2014 May;9(5):1533-41. doi: 10.3892/mmr.2014.2040. Epub 2014 Mar 11.

Unveiling a prescribing cascade in an older man

Rosenberg J, Rochon PA, Gill SS.

J Am Geriatr Soc. 2014 Mar;62(3):580-1. doi: 10.1111/jgs.12714.

Dementia in a dish

Doege CA, Abeliovich A.

Biol Psychiatry. 2014 Apr 1;75(7):558-64. doi: 10.1016/j.biopsych.2014.01.007. Epub 2014 Jan 27.

Network dysfunction in Alzheimer's disease and frontotemporal dementia: implications for psychiatry

Zhou J, Seeley WW.

Biol Psychiatry. 2014 Apr 1;75(7):565-73. doi: 10.1016/j.biopsych.2014.01.020. Epub 2014 Feb 4.

Brain insulin resistance in Alzheimer's disease and its potential treatment with GLP-1 analogs

Talbot K.

Neurodegener Dis Manag. 2014;4(1):31-40. doi: 10.2217/nmt.13.73.

From epidemiology to pathophysiology: what about caffeine in Alzheimer's disease?

Flaten V, Laurent C, Coelho JE, Sandau U, Batalha VL, Burnouf S, Hamdane M, Humez S, Boison D, Lopes LV, Buée L, Blum D.

Biochem Soc Trans. 2014 Apr;42(2):587-92. doi: 10.1042/BST20130229.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias